معرفی
Dr. David Gomez Varela is a Senior Scientist at the University of Vienna's Department of Pharmaceutical Sciences, affiliated with the Division of Pharmacology and Toxicology. He holds a permanent position and directs the University of Vienna-Bruker Center of Excellence for Metaproteomics. His roles include leading interdisciplinary projects in proteomics, machine learning, and personalized health solutions. Previously, he worked at UC San Diego and the Max Planck Institute for Experimental Medicine, where he developed novel proteomic techniques like Data Independent Acquisition (DIA).
Education: PhD in Biochemistry from Oviedo University (Spain), postdoctoral research in ion channel electrophysiology and microscopy at the Max Planck Institute (Germany), and senior scientist roles in the US and Germany.
Research focuses on chronic pain mechanisms, host-microbiome interactions, and microbiome-driven drug discovery. Key projects include CODOP/COEWS algorithms for predicting COVID-19 outcomes and the SaLux pocket PCR machine. Recent publications emphasize proteomic profiling of pain signatures, microbiome interactions, and age/sex differences in neural tissues.
Currently leads a team deploying DIA-PASEF mass spectrometry, ML analysis, and mouse behavior studies to identify chronic pain targets. The Center of Excellence for Metaproteomics collaborates with Bruker to advance LC-MS and AI for microbiome studies in health ecosystems.
Grants and advising: Directed international teams in pandemic response projects, validated >40,000 patient data. Active in mentoring postdocs and PhD students in proteomics and systems biology.
Labs/Teams: Director of the Vienna-Bruker Center, leading the Pharmacology & Toxicology Division's proteomics initiatives. Collaborates globally on translational medicine projects.
